Report overview
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
This report aims to provide a comprehensive presentation of the global market for Blood Plasma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma. This report contains market size and forecasts of Blood Plasma in global, including the following market information:
Global Blood Plasma Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Blood Plasma Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Blood Plasma companies in 2022 (%)
The global Blood Plasma market was valued at US$ 418.5 million in 2022 and is projected to reach US$ 487.7 million by 2029, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
We surveyed the Blood Plasma manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Plasma Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blood Plasma Market Segment Percentages, by Type, 2022 (%)
Immunoglobulin
Albumin
Protease Inhibitors
Coagulation Factor Concentrates
Others
Global Blood Plasma Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blood Plasma Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Research Laboratories
Academic Institutions
Global Blood Plasma Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blood Plasma Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Plasma revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Blood Plasma revenues share in global market, 2022 (%)
Key companies Blood Plasma sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Blood Plasma sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter International
CSL
Grifols
Octapharma
ADMA Biologics
Cerus Corp
Sanquin
Shanghai Raas
TCS Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood Plasma, market overview.
Chapter 2: Global Blood Plasma market size in revenue and volume.
Chapter 3: Detailed analysis of Blood Plasma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood Plasma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blood Plasma capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
